Moxibustion for the treatment of diabetic peripheral neuropathy: A systematic review and meta-analysis following PRISMA guidelines

Main idea: Moxibustion demonstrated promising results in neuropathy treatment..

Abstract: Only 1 study reported that treatment groups experienced no adverse reactions. Toronto Clinical Scoring System indicated a significant decrease in the treatment groups. The other 10 studies did not mention adverse events. Moxibustion therapy may be an effective and safe option for DPN patients but needs to be verified in further rigorous studies. There was also an increase in median SNCV and peroneal SNCV (MD 3. The treatment groups receiving moxibustion therapy indicated a more significant improvement in total effectiveness rate. We included randomized controlled trials (RCTs) applying moxibustion therapy with a minimum of 14-day treatment duration for DPN patients compared with placebo, no intervention, or conventional WM interventions. Moxibustion is a representative external treatment in traditional Chinese medicine that has been beneficial to DPN.

Source MD-Journal